Development of head control and vestibular responses in infants treated with aminoglycosides.
D002547:Cerebral Palsy / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D005839:Gentamicins / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D007612:Kanamycin / Q000009:adverse effects* / Q000627:therapeutic use; D007759:Labyrinth Diseases / Q000139:chemically induced*; D008297:Male; D009759:Nystagmus, Pathologic / Q000139:chemically induced; D011187:Posture; D018805:Sepsis / Q000188:drug therapy*; D014724:Vestibular Function Tests; D014722:Vestibule, Labyrinth / Q000187:drug effects*
D005839:Gentamicins; D007612:Kanamycin